Mutational analysis of the peroxisome proliferator-activated receptor γ in human malignancies

Medicine and Dentistry

• Peroxisome Proliferator Activated Receptor 100%
• Receptor Gene 45%
• Colon 45%
• Cancer 45%
• Malignant Neoplasm 27%
• Colon Cancer 27%
• Cancer Cell 18%
• Reverse Transcription Polymerase Chain Reaction 18%
• Nuclear Hormone Receptor 18%
• Single Strand Conformation Polymorphism 18%
• Differentiation 18%
• Lung Cancer 9%
• Prostate Cancer 9%
• Breast Cancer 9%
• Hematologic Malignancy 9%
• Tumor Suppressor Gene 9%
• Cell Growth 9%
• Chromosome Aberration 9%
• Leukemia 9%
• Adipocyte 9%
• Polymerase Chain Reaction 9%
• Mutational Analysis 9%
• Chromosome Band 9%
• Analysis 9%
• Cells 9%
• Tissues 9%
• Breast 9%
• Cell Line 9%

Biochemistry, Genetics and Molecular Biology

• Peroxisome Proliferator-Activated Receptor 100%
• Receptor Gene 45%
• Sample 27%
• Cancer Cell 18%
• Mutation 18%
• Reverse Transcription Polymerase Chain Reaction 18%
• Single-Strand Conformation Polymorphism 18%
• Adipocyte 9%
• Polymerase Chain Reaction 9%
• Cell Growth 9%
• Gene Mutation 9%
• Chromosomal Abnormalities 9%
• Chromosome Band 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor 100%
• Colon Cancer 27%
• Malignant Neoplasm 27%
• Western Blot 27%
• Breast Cancer 9%
• Leukemia 9%
• Lung Cancer 9%
• Prostate Cancer 9%
• Chromosome Aberration 9%
• Hematologic Malignancy 9%